Protagenic Therapeutics shares owned by Warberg Asset Management
Quarter-by-quarter ownership of Protagenic Therapeutics (PTIXW) shares owned by Warberg Asset Management
from 13F filings
Historical chart of Warberg Asset Management investment in Protagenic Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagenic Therapeutics held by Warberg Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagenic Therapeutics by Warberg Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.6k | 177k | 0.01 |
| 2023-09-30 | $5.3k | 177k | 0.03 |
| 2023-06-30 | $5.9k | 177k | 0.03 |
| 2023-03-31 | $4.3k | 177k | 0.02 |
| 2022-12-31 | $7.3k | 177k | 0.04 |
| 2022-09-30 | $12k | 286k | 0.04 |
| 2022-06-30 | $49k | 328k | 0.15 |
| 2022-03-31 | $78k | 362k | 0.22 |
| 2021-12-31 | $69k | 182k | 0.38 |
| 2021-09-30 | $143k | 365k | 0.39 |
| 2021-06-30 | $260k | 366k | 0.71 |
Top funds holding Protagenic Therapeutics
View all funds holding Protagenic Therapeutics